US Patent 11299490 Benzenesulfonamide compounds and their use as therapeutic agents
Patent 11299490 was granted and assigned to Xenon Pharmaceuticals on April, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 28, 2020
Date of Patent
April 12, 2022
Patent Applicant
Patent Application Number
16940696
Patent Citations
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11299490 Benzenesulfonamide compounds and their use as therapeutic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
